|
BIBLIOGRAFIA
1- Williams G. Tratamiento de la Diabetes no
insulinodependiente.The Lancet (Ed. Esp.) 1994; 24: 287-293.
2- Generalitat de Catalunya. Departament de Sanitat i Seguretat
Social. "Prevalença de diabetis mellitus no
insulinodependent a Catalunya". Butlletí
Epidemiològic de Catalunya 1997; XVIII (3): 41-43.
3- Generalitat de Catalunya. Departament de Sanitat i Seguretat
Social. "El registre de diabetis mellitus insulinodependent
(DMID) a Catalunya". Butlletí Epidemiològic de
Catalunya 1995; XVI (11): 155-163.
4- Anàlisi de la mortalitat de Catalunya 1996.
Departament de Sanitat i Seguretat Social. Generalitat de Catalunya.
5- Birulés M, Cano JF, Franch J, Hernández E i
grup d'Estudi de la Diabetis a la Atenció Primària de
Salut (GEDAPS) "Nous criteris diagnòstics i de
classificació de la diabetis mellitus". Butlletí
de la societat catalana de medicina familiar i comunitària
1998; 72: 12-15.
6- . US, Preventive Services Task Force. Screening for Diabetes
Mellitus. A: Guide to Clinical Preventive Services 1996;193-208.
7- Patchett P, Roberts D. Diabetic patients who don not have
diabetes investigation of register of diabetic patients in general
practice. BMJ 1994; 308: 1225-1226.
8- Bingley PJ, Bonifacio E, Shattock M Gillmor HA, Sawtell PA,
Dunger DB, Scott RD, Bottazzo GF, Gale EA. "Can islet cell
antibodies predict IDDM in the general population?" Diabetes
Care 1993; 16(1): 45-50.
9- Canadian Task Force on the Periodic Health Examination.
Canadian guide to clinal preventive health care. Otawa: Canada
Communication Group 1994: 16-23, 601-609.
10- American Diabetes Association. "Gestational Diabetes
Mellitus". Diabetes Care 1999; 22(1): 74-76.
11- The Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus: "Report of the Expert Committee on the
Diagnosis and Classification of Diabetes Mellitus". Diabetes
Care 1997;20 (Suppl 1): 1183-1197.
12- De Vegt F, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM,
Heine RJ. The 1997 "American Diabetes Association Criteria
Versus the 1985 World Health Organization Criteria for the Diagnosis
of Abnormal Glucose Tolerance". Diabetes Care 1998; 21 (10): 1686-1690.
13- Report of the Expert Comittee on the diagnosis and classification
of the diabetes mellitus. Diabetes Care 1997; 20: 1.193-7.
14- Sociedad Española de Medicina de Familia y
Comunitaria. "Alteraciones de la glucemia". A: Guía
de Actuación en Atención Primaria. Ed. EDIDE 1998; 1054-1060.
15- Guidelines subcommittee. 1999 World Health Organisation -
"International society of hypertension guidelines for the
management of hypertension". Journal of hypertension 1999; 17: 151-83.
16- The Diabetes Control and Complications Trial research Group.
The effect of intensive treatment of diabetes on the development and
progression on long-term complications in insulin-dependent diabetes
mellitus. N Engl J Med. 1993; 329: 977-986.
17- Klein R, Klein BE, Moss SE. Relation of Glycemic Control to
Diabetic microvascular Complications in Diabetes Mellitus. Ann Intern
Med 1996; 124 (1Pt 2): 90-96.
18- Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of
intensive blood-glucose control on late complications of type I
diabetes. Lancet 1993; 341(8856): 1306-1309.
19- Schiffrin AD, Desrosiers M, Aleyassine H, Belmonte MM.
Intensified insulin therapy in the type I diabetic adolescent: a
controlled trial. Diabetes Care 1984; 7: 107-113.
20- Mecklenburg RS, Benson EA, Benson JW Fredlund PN, Guinn T,
Metz RJ, Nielsen RL, Sanner CA. Acute complications associated with
insulin infusion pump therapy. Report of experience with 161
patients. JAMA 1984; 252(23): 3265-3269.
21- Padgett D, Mumford E, Hynes M, Carter R. Meta-analysis of the
effects of educational and psychosocial interventions on management
of diabetes mellitus. J Clin Epidemiol 1988; 41(10): 1007-1030.
22- Brown SA. Effects of educational interventions in diabetes
care: a meta-analysis of findings. Nurs Res 1988; 37(4): 223-230.
23- Brown SA. Studies of educational interventions and outcomes
in diabetic adults: a meta-analysis revisited. Patient Educ Couns
1990; 16(3): 189-215.
24- Nicolucci A, Cavaliere D, Scorpiglione N, Carinci F, Capani
F, Tognoni G, Benedetti MM. A comprehensive assessment of the
avoidability of long-term complications of diabetes. A case-control
study. SID-AMD Italian Study Group for the Implementation of the St.
Vincent Declaration. Diabetes Care 1996; 19(9): 927-933.
25- Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb
amputation. Basis for prevention. Diabetes Care 1990; 13(5): 513-521.
26- Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA,
Bild DE, Ford ES, Vinicor F. Reduction in lower extremity clinical
abnormalities in patients with non-insulin-dependent diabetes. A
randomized, controlled trial. Ann Intern Med 1993; 119(1): 36-41.
27- Lloveras G, Salgado A. Diabetologia: anàlisi
crítica. Rubes Ed. Barcelona, 1999.
28- Raz I, Soskolne V, Stein P. Influence of small-group
education sessions on glucose homeostasis in NIDDM. Diabetes Care
1988; 11(1): 67-71.
29- Muhlhauser I, Berger M. Diabetes education and insulin
therapy: when will they ever learn? J Intern Med 1993; 233(4): 321-326.
30- Clement S. Diabetes self-management education. Diabetes Care
1995; 18(8): 1204-1214.
31- Exercise and NIDDM. Diabetes Care 1990; 13: 785-789.
32- Wasserman DH, Zinman B. Exercise in individuals with IDDM.
Diabetes Care 1994; 17: 924-937.
33- Pugh JA, Wagner ML, Sawyer S, Ramirez G, Tuley M, Friedberg
SJ. Is combination sulphonylureas and insulin therapy useful in NIDDM
patients? Diabetes Care 1992; 15(8): 953-959.
34- Garcia MJ, Mc Namara PM, Gordon T Kannel WB. Morbidity and
mortality in diabetics in the Framingham population. Sixteen year
follow-up study Diabetes 1974; 23(2): 105-111.
35- Teuscher A, Egger M, Herman JB: Diabetes and hypertension:
blood pressure in clinical diabetic patients and a control
population. Arch Intern Med 1989; 149(9): 1942-1945.
36- Kannel WB, McGee DL. Diabetes and cardiovascular disease. The
Framingham study. JAMA 1979; 241(19): 2035-2038.
37- Parving HH. Impact of blood pressure and antihypertensive
treatment on incipient and over nephropathy, retinopathy and
endothelial permeability in diabetes mellitus. Diabetes Care 1991;
14(3): 260-269.
38- The Working Group on Hypertension in Diabetes. Statement on
hypertension in diabetes mellitus. Arch Intern Med 1987; 147(6): 830-842.
39- Mogensen CE, Christensen CK. Predicting diabetic nephropathy
in insulin-dependent diabetic patients. N Engl J Med 1984; 311(2): 89-93.
40- Marshal SM. Blood pressure control, microalbuminuria and
cardiovascular risk in type 2 diabetes mellitus. Diabet Med 1999; 16: 358-72.
41- American Diabetes Association. Nutrition recommendation and
principles for people with diabetes mellitus. Diabetes Care 1999; 22
(Suppl 1): S42-S45.
42- American Diabetes Association. Diabetes and exercise.
Diabetes Care 1999; 22 (Suppl 1): S42-S45.
43- Lloveras G, Castell C. Lloveras A, Salvador G, Goday.
Diabetis. Monografies Mèdiques. Ed. Doyma 1992.
44- American Diabetes Association. Hospital Admission Guidelines
for Diabetes Mellitus. Diabetes Care 1999; 22(Suppl 1): S80.
45- Lloveras G, Castell C. Lloveras A, Salvador G, Goday A.
Complicacions tardanes de la diabetis: microangiopatia i
macroangiopatia. Neuropatia. A: Diabetis. Monografies Mèdiques.
Ed. Doyma 1992; 84-115.
46- Klein BE, Klein R, Meuer SM, Moss SE, Dalton DD. Does the
severity of diabetic retinopathy predict pregnancy outcome? J Diabet
Complications 1998; 2(4): 179-184.
47- Expert Committee of the Canadian Diabetes Advisory Board.
Clinical practice guidelines for treatment of diabetes mellitus. Can
Med Assoc J 1992; 147 (5): 697-712.
48- Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ,
Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR. Magnitude and
determinants of coronary artery disease in juvenile-onset,
insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59(8):750-755.
49- Morrish NJ, Stevens LK, Head J Fuller JH, Jarrett RJ, Keen H.
A prospective study of mortality among middle-aged diabetic patients
(the London Cohort of the WHO Multinational Study of Vascular Disease
in Diabetics) I: Causes and death rates. Diabetologia 1990; 33(9): 538-541.
50- Donahue RP, Orchard TJ. Diabetes Mellitus and macrovascular
complications. An epidemiological perspective. Diabetes Care 1992;
15(9): 1141-1152.
51- Bell D. Stroke in diabetic patient. Diabetes Care 1994; 17: 213-219.
52- Stamler J, Vaccaro O, Neaton JD Wentworth D. Diabetes, other
risk factors, and 12-yr cardiovascular mortality for men screened in
the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
53- Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP,
Kwaan HC, Nuttall F. Veterans Administration Cooperative Study on
antiplatelet agents in diabetic patients after amputation for
gangrene:II. Effects of aspirin and dipyridamole on atherosclerotic
vascular disease rates. Diabetes Care 1986; 9(2): 140-148.
54- Pyorala K, Uusitupa M, Laakso M, Siitonen O, Niskanen L,
Ronnemaa T. Macrovascular complications in relation to
hyperinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes
Metab 1987; 13(3 Pt 2): 345-349.
55- Ronnemaa T, Laakso M, Pyorala K, Kallio V, Puukka P. High
fasting plasma insulin is an indicator of coronary heart disease in
non-insulin-dependent diabetic patients and nondiabetic subjects.
Arterioscler Thromb 1991; 11(1): 80-90.
56- Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala
K. Ten-year cardiovascular mortality in relation to risk factors and
abnormalities in lipoprotein composition in type 2 (non-insulin
dependent) diabetic and non-diabetic subjects. Diabetologia 1993;
36(11): 1175-1184.
57- Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia
does not increase the risk of fatal cardiovascular disease in elderly
men or women without diabetes: the Rancho Bernardo Study 1984-1991.
Am J Epidemiol 1994; 140(10): 857-869.
58- Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its
metabolic control predict coronary heart disease in elderly subjects.
Diabetes 1994; 43(8): 960-967.
59- Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a
heart disease risk factor. Diabetes Care 1995; 18(9): 1299-1304.
60- Moser M, Ross H. The treatment of hypertension in diabetic
patients. Diabetes Care 1993; 16(2): 542-547.
61- Muhlauser I. Diabetes y tabaco. Avances en diabetología
1992; 5 (Suppl 3): S70-S71.
62- Diabetes Care and Research in Europe. The Saint Vincent
Declaration. Giornale Ital Diabetol 1990; 10: 143-144.
63- Antiplatelet Trialists Collaboration. Collaborative overview
of randomized trials of antiplatelet therapy, I: prevention of death,
myocardial infarction, and stroke by prolonged antiplatelet therapy
in various categories of patients. Br Med J 1994; 308: 81-106.
64- Aspirin effects on mortality and morbidity in patients with
diabetes mellitus. Early Treatment Diabetic Retinopathy Study report
14 ETDRS. JAMA 1992; 268 (10): 1292-1300.
65- American Diabetes Association. Aspirin Therapy in Diabetes.
Diabetes Care 1999, 22 (Suppl 1): S60-S61.
66- Final report on the aspirin component of the ongoing
Physicians' Health Study. Steering Committee of the Physicians'
Health Study Research Group. N Engl J Med 1989; 321(3): 129-135.
67- Colwell JA: Aspirin therapy in diabetes. Diabetes Care 1997;
20(11): 1767-1771.
68- Sociedades Españolas de Diabetes,
Endocrinología, Medicina Familiar y Comunitaria y
Nefrología. Documento de consenso sobre pautas de
detección y tratamiento de la nefropatía
diabética en España. Nefrología 1997; XVII (6): 467-474.
69- Borch Johnsen K, Andersen PK, Deckert T. The effect of
proteinuria on relative mortality in type 1 (insulin-dependent)
diabetes mellitus. Diabetologia 1985; 28: 590-596.
70- Esmatjes E, Castell C, Goday A, Montanya E, Pou JM, Salinas
I, Simó R, González MT, Tresserras R, Lloveras G.
Prevalencia de nefropatia en la diabetes mellitus tipo I. Med Clin
(Barc) 1998; 110: 6-10.
71- Esmatjes E, Castell C, Gonzalez T, Tresserras R, Lloveras G.
Epidemiology of renal involvement in Type II diabetics (NIDDM) in
Catalonia. The Catalan Nephropathy Study Group. Diabetes Res Clin
Pract 1996; 32(3): 157-163.
72- Generalitat de Catalunya. Departament de Sanitat i Seguretat
Social. Pla de salut de Catalunya 1996-1998.
73- Richard P, Nilsson BY, Rosenqvist U. The effect of long-term
intensified insulin treatment on the development of microvascular
complications of diabetes mellitus. N Engl J Med 1993; 329(5): 304-309.
74- Intensive blood glucose control with sulphanylureas or
insulin compared with conventional treatment and risk of
complications in patients with type 2 diabetes (UKPDS33). UK
Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352(9131): 837-853.
75- Ohkubo Y, Kishilkawa H, Araki E, Miyata T, Isami S, Motoyoshi
S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy
prevents the progression of diabetic microvascular complications in
Japanese patients with non-insulin-dependent diabetes mellitus: a
randomized prospective 6-year-study. Diabetes Res Clin Pract 1995;
28(2): 103-117.
76- Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW.
Clinical factors associated with urinary albumin excretion in type II
diabetes. Am J Kidney Dis 1995; 25(6): 836-844.
77- Chuang LM, Jou TS, Wu HP, Tseng CH, Tai TY, Lin BJ. Effect of
treatment of borderline hypertension on microalbuminuria in
non-insulin-dependent diabetes mellitus. J Formos Med Assoc 1991;
90(6): 531-535.
78- Mogensen CE. Management of diabetic renal involvement and
disease. Lancet 1988; 1(8590): 867-869.
79- Mogensen CE. Microalbuminuria predicts clinical proteinuria
and early mortality in maturity-onset diabetes. N Engl J Med 1984;
310(6): 356-360.
80- Vijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ.
Screening, Prevention, Counseling, and Treatment for the
Complications of Type II Diabetes Mellitus. Putting Evidence into
Practice. J of Gen Intern Med 1997; 12: 567-580.
81- American Diabetes Association. Diabetic Nephropathy. Diabetes
Care 1999; 22 (suppl): S66-S69.
82- Lloveras G, Castell C. Lloveras A, Salvador G, Goday A.
Epidemiologia de la diabetis. A: Diabetis. Monografies
Mèdiques. Ed. Doyma 1992; 21-49.
83- Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M.
Long-term stabilizing effect of angiotensin-converting enzyme
inhibition on plasma creatinine and on proteinuria in normotensive
type II diabetic patients. Ann Intern Med 1993; 118(8): 577-581.
84- Ravid M, Lang R, Rachmani R, Lishner M. Long-term
renoprotective effect of angiotensin-converting enzyme inhibion in
non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Arch Intern Med 1996; 156(3): 286-289.
85- Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect
of dietary protein restriction on the progression of diabetic and
non-diabetic renal diseases: a meta-analysis. Ann Intern Med 1996;
124(7): 627-632.
86- Generalitat de Catalunya. Departament de Sanitat i Seguretat
Social. Atenció i recerca diabetològica a Europa: La
Declaració de St. Vincent. Document d'aplicació.
Barcelona, 1995.
87- Photocoagulation treatment of proliferative diabetic
retinopathy. Clinical application of Diabetic Retinopathy Study
findings, DRS Report Number 8. The Diabetic Retinopathy Study
Research Group. Ophthalmology 1981; 88(7): 583-600.
88- Early Treatment Diabetic Retinopathy Study Report Number 2.
Early Treatment Diabetic Retinopathy Study Research Group Treatment
techniques and clinical guidelines for photocoagulation of diabetic
macular edema (report 2), Ophthalmology 1987; 94: 761-774.
89- Early photocoagulation for diabetic retinopathy. ETDRS report
Number 9. Early Treatment Diabetic Retinopathy Study Research Group.
Ophthalmology 1991; 98 (Suppl 5): 766-785.
90- American Diabetis Association. Diabetic Retinopathy.
Diabetes Care 1999; 22 (Suppl 1): S70-S73.
91- Pirart J. Diabetes mellitus and its degenerative
complications: a prospective study of 4,400 patients observed between
1947 and 1973. Diabete Metab 1977; 3: 97-107 (Pt 1), 173-182 (Pt 2)
and 245-256 (Pt 3).
92- Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL. Is blood
pressure a predictor of the incidence of progression of diabetic
retinopathy? Arch Intern Med 1989; 149(11): 2427-2432.
93- Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P,
Showstack JA. Lower extremity amputation, in people with diabetes
epidemiology and prevention. Diabetes Care 1989; 12(1): 24-31.
94- Uccioli L, Faglia E, Monticone G, Favales F, Durola L,
Aldeghi A, Quarantiello A, Calia P, Menzinger G. Manufactured shoes
in the prevention of diabetic foot ulcers. Diabetes Care 1995;
18(10): 1376-1378.
95- Canturk Z, Canturk NZ, Onen F. Effects of rhG-CSF on
neutrophil functions and survival in sepsis induced diabetic
rats.Endocr Res 1998; 24 (2): 141-157.
96- Tsujino M, Kimpara I, Nakamura T, Suda T, Saitou Y, Kudou H,
Yasujima M, Hirai Y, Nakahata H, Kumasaka Y, Imamura K, Takebe K.
Peripheral lymphocyte subset of patients with pancreatic diabetes
mellitus-about a decreased ratio of T-LGL and ability of host
defense. Kansenshogaku Zasshi 1996; 70 (4): 325-330.
97- Salleras Sanmartí. Vacunaciones preventivas.
Principios y aplicaciones. Masson, Barcelona, 1998.
98- American Diabetes Association. Preconception care of women
with diabetes. Diabetes Care 1999; 22 (Suppl 1): 62-65.
99- Goldman JA, Dickerd D, Feldberg D. Pregnancy outcome in
patients with insulin-dependent diabetes mellitus with pre-conceptual
diabetic control: a comparative study. Am J Obstet Gynecol 1986; 155: 193-197.
100- Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van
Allen M, Aarons JH, Metzger B, Bieber FR, Knopp RH, Holmes LB, et al.
Incidence of spontaneous abortion among normal women and women
insulin-dependent diabetic women whose pregnancies were identified
within 21 days of conception. N Engl J Med. 1988; 319(25): 1617-1623.
101- Stell JM, Jonstone FD, Hepburn DA, Smith A. Can prepregnancy
care of diabetic women reduce the risk of abnormal babies? BMJ 1990;
301: 1070-1074.
102- Kitzmiller JL, Gavin LA, Gin GD, Jovanovic L, Main EK,
Zigrang WD. Preconception care of diabetes: glycemic control prevents
congenital anomalies. JAMA 1991; 265: 731-736.
|
